SCHEMBL29349759

SCHEMBL29349759

NCCCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 4/20 0.57
▸ NPY1R P25929 3/20 0.57
▸ NPY2R P49146 3/20 0.57
▸ ENPEP Q07075 5/20 0.52
▸ ERAP2 Q6P179 1/20 0.51
▸ LNPEP Q9UIQ6 1/20 0.51
▸ NPY5R Q15761 2/20 0.50
▸ NTSR2 O95665 2/20 0.50
▸ NTSR1 P30989 2/20 0.50
▸ CHRNA1 P02708 1/20 0.48
▸ CHRNG P07510 1/20 0.48
▸ CHRNB1 P11230 1/20 0.48
▸ CHRND Q07001 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30974367 0.96 NPY4R (0.58) NPY4RNPY1RNPY2RENPEPERAP2
SCHEMBL30179294 0.94 NPY4R (0.63) NPY4RNPY1RNPY2RENPEPERAP2
SCHEMBL27942027 0.93 NPY4R (0.62) NPY4RNPY1RNPY2RENPEPERAP2
Lysyl-Tyrosyl-Lysine Acetate SCHEMBL6275116 0.93 NPY4R (0.62) NPY4RNPY1RNPY2RENPEPERAP2
Lysyl-Tyrosyl-Lysine Acetate SCHEMBL6275111 0.93 NPY4R (0.62) NPY4RNPY1RNPY2RENPEPERAP2
SCHEMBL30851358 0.92 NPY4R (0.63) NPY4RNPY1RNPY2RENPEPERAP2
SCHEMBL1373290 0.92 NPY4R (0.59) NPY4RNPY1RNPY2RERAP2LNPEP
SCHEMBL15011504 0.92 NPY4R (0.59) NPY4RNPY1RNPY2RERAP2LNPEP
SCHEMBL1373292 0.92 NPY4R (0.59) NPY4RNPY1RNPY2RERAP2LNPEP
SCHEMBL30973975 0.91 ERAP2 (0.54) NPY4RNPY1RNPY2RENPEPERAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2380 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260091078-A1 OLIGOPEPTIDE THAT INHIBITS ANGIOGENESIS AND VASCULAR FUNCTION TRIEBEL JAKOB (DE) 2026-04-02 — — US claimed
US-11820804-B2 Peptide-based inhibitors of growth hormone action and methods of use thereof OHIO UNIVERSITY (US) 2023-11-21 — — US claimed
US-20230085176-A1 PEPTIDE-BASED INHIBITORS OF GROWTH HORMONE ACTION AND METHODS OF USE THEREOF OHIO UNIVERSITY (US) 2023-03-16 — — US claimed
US-11524986-B2 Peptide-based inhibitors of growth hormone action and methods of use thereof OHIO UNIVERSITY (US) 2022-12-13 — — US claimed
EP-4061394-A1 OLIGOPEPTIDE THAT INHIBITS ANGIOGENESIS AND VASCULAR FUNCTION Universidad Nacional Autónoma De México (MX) 2022-09-28 — — EP claimed
CN-114728038-A Oligopeptides for inhibiting angiogenesis and vascular function 墨西哥国立自治大学 2022-07-08 — — CN claimed
CN-117003803-B Crystal form of trisaccharide Hengrui (Qingdao) Biotechnology Co.,Ltd. (CN) 2026-05-26 — — CN disclosed
CN-106987570-B Cas9 nuclease R780A and application thereof SHANGHAI JIAO TONG UNIVERSITY (CN) 2026-05-26 — — CN disclosed
CN-107513103-B MASP isoforms as inhibitors of complement activation OMEROS CORP. (US) 2026-05-26 — — CN disclosed
CN-122080238-A RBoNT recombinant protein and precursor thereof, and preparation method and application thereof — 2026-05-26 — — CN disclosed
CN-116355945-B Application of MYB3R1 gene in regulation and control of root nodule number of nodule plant Center for excellence and innovation in molecular plant science, Chinese Academy of Sciences (CN) 2026-05-26 — — CN disclosed
CN-112752837-B Natural killer cells 帝国理工学院创新有限公司 2026-05-15 — — CN disclosed
US-12617971-B2 Anti-viral coating composition, and method for fixing anti-viral fusion protein to surfaces AMOLIFESCIENCE CO., LTD. (KR) 2026-05-05 — — US disclosed
CN-108815506-B Application of scabies mite chitinase-like protein gene and/or protein expressed by scabies mite chitinase-like protein gene 四川农业大学 2022-01-28 — — CN disclosed
CN-113975393-A Methods of treating gefitinib resistant cancers 综合医院公司 2022-01-28 — — CN disclosed
CN-107074948-B Antibodies that bind AXL 根马布股份公司 2022-01-28 — — CN disclosed
CN-113993989-A Process for producing ergothioneine 丹麦科技大学 2022-01-28 — — CN disclosed
CN-113967253-A Immunotherapy by disrupting PD-1/PD-L1 signaling 百时美施贵宝公司 2022-01-25 — — CN disclosed
CN-113952338-A Methods of treating gefitinib resistant cancers 综合医院公司 2022-01-21 — — CN disclosed
CN-113952459-A Methods of treating gefitinib resistant cancers 综合医院公司 2022-01-21 — — CN disclosed
Send feedback